
Keywords: Tuberculosis; Rifampicin; Nanoparticle; MPEO-b-PCL; FRET; C120; coumarin 120; DACCA; 7-(diethylamino)-coumarin-3-carboxylic acid; DL; drug loading; DMEM; Dulbecco's modified Eagle's medium; EE; entrapment efficiency; FDA; fluorescein diacetate; FRET; För